SG

Shamikant Gupta

Active Director Designated Partner DIN 10021652
DIN 10021652 First appointment Sep 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shamikant Gupta

Data last updated:

Shamikant Gupta is a Designated Partner at Mediopts Lifesciences Llp (since 2022). The company operates in Business Services.

DIN 10021652
Primary Designation Designated Partner
Industry Business Services
First Appointment 28 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Sep 20222022Active

Board colleagues of Shamikant Gupta

NameDINCompanyDesignation
Prakash Kumar10021654Mediopts Lifesciences LlpDesignated Partner
Rohit Kumar Mahato10021653Mediopts Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mediopts Lifesciences Llp
Premium access

Shareholding and investment profile for Shamikant Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shamikant Gupta

Shamikant Gupta currently holds 1 directorship: Mediopts Lifesciences Llp (Designated Partner, since 28 Sep 2022).

Shamikant Gupta was first appointed on 28 Sep 2022 as Designated Partner at Mediopts Lifesciences Llp.

The current boards of Shamikant Gupta's companies include Prakash Kumar (Mediopts Lifesciences Llp), Rohit Kumar Mahato (Mediopts Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available